Next Level Private LLC Boosts Position in UnitedHealth Group Incorporated $UNH

Next Level Private LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 163.8% during the second quarter, Holdings Channel reports. The firm owned 1,021 shares of the healthcare conglomerate’s stock after buying an additional 634 shares during the quarter. Next Level Private LLC’s holdings in UnitedHealth Group were worth $319,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in UNH. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Tang Capital Management LLC increased its stake in UnitedHealth Group by 62.3% in the fourth quarter. Tang Capital Management LLC now owns 2,308 shares of the healthcare conglomerate’s stock valued at $1,168,000 after purchasing an additional 886 shares during the last quarter. Strive Asset Management LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $404,000. Finally, Strategic Wealth Partners Ltd. increased its stake in UnitedHealth Group by 108.2% in the fourth quarter. Strategic Wealth Partners Ltd. now owns 13,202 shares of the healthcare conglomerate’s stock valued at $7,013,000 after purchasing an additional 6,860 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $352.61 on Monday. The firm has a market cap of $319.35 billion, a P/E ratio of 15.28, a P/E/G ratio of 2.30 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a fifty day moving average of $291.98 and a two-hundred day moving average of $368.31.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analyst Ratings Changes

Several equities research analysts have commented on UNH shares. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Wells Fargo & Company dropped their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Wolfe Research decreased their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Finally, KeyCorp decreased their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.